Skip to main content
OpenTrials

Clinical trial condition

Lymphoblastic Leukemia, Acute, Childhood

Explore clinical trials studying Lymphoblastic Leukemia, Acute, Childhood. Study availability and eligibility vary by location and protocol.

13 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Lymphoblastic Leukemia, Acute, Childhood trial results

Recruiting

Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL

NCT05495035

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Qilu Hospital of Shandong University Jinan, Shandong, China
  • Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
  • Department of Hematology/Oncology, Shanghai Jiaotong University School of Medicine Affiliated Shanghai Children's Medical Center Shanghai, China
View Trial Details
Active, not recruiting

PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

NCT03817320

Conditions
ALL, Childhood, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Miami Miami, Florida, United States
View all 18 locations
View Trial Details
Completed

Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy

NCT02879643

Conditions
ALL, Childhood, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • The Children's Hospital, University of Colorado Aurora, Colorado, United States
View all 35 locations
View Trial Details
Completed

A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma

NCT01614197

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +19 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • The Children's Hospital, University of Colorado Aurora, Colorado, United States
View all 32 locations
View Trial Details
Completed

AC220 for Children With Relapsed/Refractory ALL or AML

NCT01411267

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Central California Madera, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • The Children's Hospital, University of Colorado Aurora, Colorado, United States
View Trial Details
Completed

A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML

NCT01861002

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta, Emory University Atlanta, Georgia, United States
View all 23 locations
View Trial Details

Related conditions